Toggle SGML Header (+)


Section 1: 8-K (8-K)

aac-8k_20190830.htm

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): August 30, 2019

 

AAC HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

 

 

Nevada

 

001-36643

 

35-2496142

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 

 

 

200 Powell Place

Brentwood, Tennessee

(Address of Principal Executive Offices)

 

37027

(Zip Code)

(615) 732-1231

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

AAC

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


 

 

Item 2.02.

Results of Operations and Financial Condition.

 

On August 30, 2019, AAC Holdings, Inc. (the “Company”) issued a press release (the “Press Release”) announcing its results of operations for the quarter ended June 30, 2019. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Report”) and is incorporated herein by reference.

 

The Company will conduct a conference call and live audio webcast at 8:00 a.m. (Central Time) on Friday, August 30, 2019, to discuss is results of operations for the quarter ended June 30, 2019.

 

Item 7.01  Regulation FD Disclosure.

 

The information disclosed under Item 2.02 of this Report is incorporated by reference into this Item 7.01.

 

The Company has provided an earnings release supplement that provides certain operating and financial results and information regarding its 2019 annual outlook that is available online in the Investor Relations section of the Company's website at ir.americanaddictioncenters.org., and is attached as noted below as exhibit 99.2.

 

Item 9.01

 

Exhibits and Financial Statements.

 

 

 

 

Exhibit Number

  

Description

 

 

99.1

  

Press Release, dated August 30, 2019

 

 

 

99.2

 

Earnings Release Supplement August 2019

 

  
 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

AAC HOLDINGS, INC.

 

 

By:

 

/s/ Andrew W. McWilliams

 

 

Andrew W. McWilliams

 

 

Chief Financial Officer

Date: August 30, 2019

 

(Back To Top)

Section 2: EX-99.1 (EX-99.1)

aac-ex991_6.htm

Exhibit 99.1

Investor Contact:

Andrew McWilliams

Media Contact:

Joy Sutton

 

(615) 732-1385

 

(615) 587-7728

 

[email protected]

 

[email protected]

 

 

 

 

 

AAC Holdings, Inc. Reports Second Quarter 2019 Results

BRENTWOOD, Tenn., August 30, 2019 - AAC Holdings, Inc. (NYSE: AAC) (“the Company” or “AAC”) announced financial results for the second quarter and six months ended June 30, 2019, as well as updated 2019 guidance.

Second Quarter 2019 Operational and Financial Highlights:

(All comparisons are to first quarter ended March 31, 2019, unless otherwise noted)

 

Total revenues improved by 13% to $62.7 million

 

Total inpatient census improved by 8% to 802 from 740

 

New admissions improved 4% to 4,830 from 4,641

 

Average daily inpatient revenue improved 17% to $790 from $674

 

Net loss attributable to AAC Holdings, Inc. common stockholders decreased 25% to $16.4 million, or $(0.66) per diluted common share from $22.0 million, or $(0.90) per diluted share.

 

Adjusted EBITDA improved by 144% to $2.9 million compared to $(6.5) million (see non-GAAP reconciliation herein).

“Despite the challenges we faced last year, we continue to see positive momentum in 2019 and believe that we will see continued improvement throughout the remainder of 2019,” said Michael Cartwright, AAC Chairman & Chief Executive Officer. “Inpatient census has been improving throughout 2019 and is up by 38% at June 2019 compared to December 2018. The initiatives in sales and marketing continue to show positive results as we continue to enhance our community and online outreach to those who need our help.”

“The expense savings initiatives implemented in late 2018 and in the first quarter of 2019 are having a positive impact. Operating expenses have decreased by 18% or $15 million, for the second quarter of 2019 compared to the second quarter of 2018.” Cartwright said.

Cartwright added, “We are considering initial proposals from third party investment firms as a result of the strategic transaction process being led by Cantor Fitzgerald & Co. and as we continue to show sequential improvement in our operating results we are excited optimistic about the investment interest in our Company and are engaged in talks with numerous well-regarded financing sources.”

Cost Savings Initiatives

The Company enacted a series of cost savings initiatives beginning during the fourth quarter of 2018 and continuing into 2019. These initiatives have included reductions in the Company’s corporate expenses, consolidation of its Las Vegas market, consolidation of the its southern California market, the sale of the Company’s New Orleans operations,

 

 


and the consolidation of its lab operations. Operating expenses decreased by 18% or $15.1 million for the second quarter of 2019 compared to the second quarter of 2018.

Second Quarter 2019 Financial Results

On a sequential basis total revenues increased by 13% in the second quarter of 2019 compared to the first quarter of 2019 due to improved average daily inpatient census and improved average daily inpatient revenue. Average daily inpatient census improved by approximately 8% and average daily inpatient revenue improved by 17%.

Operating expenses on a sequential basis decreased by approximately 4% to $69.1 million for the second quarter of 2019 compared to the first quarter of 2019 (excluding the litigation settlement and the gain on sale recognized in the first quarter of 2019). This was primarily due to the benefit from the cost savings initiatives enacted during the fourth quarter for 2018 and into 2019. Operating expenses on a year-over-year basis improved 18% or $15.1 million.

AAC breaks down its revenues between client related revenue and non-client related revenue. Client related revenue includes: (1) inpatient treatment facility services and related professional services; (2) outpatient facility services, related professional services and sober living services; and (3) client related diagnostic services, which includes point of care drug testing and client related diagnostic laboratory services. Non-client related revenue includes marketing and diagnostic services provided to third parties as well as addiction services provided to individuals in the criminal justice system.

Total revenues were $62.7 million for the second quarter of 2019 compared with $55.4 million for the first quarter of 2019.

 

 

 

Three Months Ended,

June 30, 2019

 

 

Three Months Ended,

March 31, 2019

 

 

Increase/

(Decrease)

 

 

% Change

 

Inpatient treatment facility services

 

$

57,690

 

 

$

44,889

 

 

$

12,801

 

 

 

28.5

 

Outpatient facility and sober living services

 

 

5,407

 

 

 

6,454

 

 

 

(1,047

)

 

 

(16.2

)

Client related diagnostic services

 

 

(2,502

)

 

 

2,146

 

 

 

(4,648

)

 

 

(216.6

)

Total client related revenue

 

 

60,595

 

 

 

53,489

 

 

 

7,106

 

 

 

13.3

 

Non-client related revenue

 

 

2,129

 

 

 

1,881

 

 

 

248

 

 

 

13.2

 

Total revenues

 

$

62,724

 

 

$

55,370

 

 

$

7,354

 

 

 

13.3

 

 

Inpatient treatment facility services revenue increased 28.5% to $57.7 million for the three months ended, June 30, 2019, compared with $44.9 million for the three months ended, March 31, 2019.

Outpatient facility and sober living services revenue decreased 16.2% to $5.4 million for the three months ended, June 30, 2019, compared with $6.5 million for the three months ended, March 31, 2019.

Client related diagnostic services revenue decreased 216.6% to $(2.5) million for the three months ended, June 30, 2019, compared with $2.1 million for the three months ended, March 31, 2019.

Non-client related revenue increased 13.2% to $2.1 million for the three months ended, June 30, 2019, compared with $1.9 million for the three months ended, March 31, 2019.

Net loss attributable to AAC Holdings, Inc. common stockholders was $(16.4) million, or $(0.66) per diluted common share for the three months ended, June 30, 2019, compared with net loss attributable to AAC Holdings, Inc. common stockholders of $(22.0) million, or $(0.90) per diluted common share for the three months ended March 31, 2019.

Adjusted EBITDA increased to $2.9 million for the three months ended, June 30, 2019, compared with $(6.5) million for the three months ended, March 31, 2019. Adjusted EBITDA, is a non-GAAP financial measure. Tables reconciling these non-GAAP measures to the most directly comparable GAAP measures are included at the end of this release.

Balance Sheet and Cash Flows

As of June 30, 2019, AAC Holdings’ balance sheet reflected cash and cash equivalents of $2.6 million, accounts receivable of $48.7 million, net property and equipment of $160.7 million and total debt of $341.9 million (current and long-term portions).

2

 


Cash flows used in operations totaled $13.5 million for the second quarter of 2019 compared to $9.6 million for the first quarter of 2019. Days sales outstanding were 71 days for the second quarter of 2019 compared to 74 days for the first quarter of 2019.

Credit Facilities

The Company is continuing discussions with lenders under its senior credit facilities to address events of defaults that have occurred relating to the Company’s compliance with certain covenants and obligations thereunder including minimum liquidity, leverage ratio and certain interest payment defaults. Management is pursuing one or more amendments to the senior credit facilities, forbearance agreements or both, which would address the Company’s current liquidity and compliance covenants.

Evaluation of Strategic Alternatives in AAC’s Real Estate Portfolio

The Company has commenced a process to generate additional value from its assets, including its real estate portfolio consisting of treatment centers located across the United States. Management’s goal is to leverage the portfolio to create additional liquidity, lower its cost of capital and enhance shareholder value. Real estate strategic alternatives could include further sale leasebacks of individual facilities or larger portions of the Company’s real estate portfolio.

2019 Outlook

AAC updates its guidance for the full year 2019 as follows:

 

 

Full Year 2019 Guidance

 

 

(in millions, except per share data)

Total Revenues

 

$255 - $275

Inpatient treatment facility revenue

 

$225 - $235

Outpatient and sober living facility revenue

 

$20 - $25

Client related diagnostic services revenue

 

$2 - $5

Non-client related revenue

 

$8 - $10

 

 

 

Adjusted EBITDA

 

$16 - $21

Adjusted Earnings per Diluted Common Share

 

$(1.80) - $(1.50)

The Company expects diluted weighted-average common shares outstanding of approximately 25.0 million for the year.

The outlook above does not include the impact of any future acquisitions, transaction-related costs, litigation settlement or expenses related to legal defenses.

With respect to the “2019 Outlook” above, reconciliation of adjusted EBITDA and adjusted earnings per diluted common share guidance to the closest corresponding GAAP measure on a forward-looking basis is not available without unreasonable efforts. This inability results from the inherent difficulty in forecasting generally and quantifying certain projected amounts that are necessary for such reconciliations. In particular, sufficient information is not available to calculate certain adjustments required for such reconciliations, including de novo start-up and other expense and acquisition-related expenses. We expect these adjustments may have a potentially significant impact on future GAAP financial results.

Earnings Conference Call

The Company has provided an earnings release supplement that provides certain operating and financial results and information regarding its 2019 annual outlook that is available online in the Investor Relations section of the Company's website at ir.americanaddictioncenters.org.

The Company will host a conference call and live audio webcast on Friday, August 30, 2019, at 8:00 a.m. CT to further discuss these results. The number to call for this interactive teleconference is 1-877-224-7960. A replay of the conference call will be available through September 13, 2019, by dialing 877-344-7529 and entering the replay access code, 10134661.

3

 


The live audio webcast of the Company's quarterly conference call will also be available online in the Investor Relations section of the Company's website at ir.americanaddictioncenters.org.

******

About American Addiction Centers

American Addiction Centers is a leading provider of inpatient and outpatient substance abuse treatment services. We treat clients who are struggling with drug addiction, alcohol addiction and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at AmericanAddictionCenters.org or follow us on Twitter.


4

 


Forward Looking Statements

This release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are made only as of the date of this release. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “may,” “potential,” “predicts,” “projects,” “should,” “will,” “would,” and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these words. Forward-looking statements may include information concerning AAC Holdings, Inc.’s (collectively with its subsidiaries; “AAC Holdings” or the “Company”) possible or assumed future results of operations, including descriptions of the Company’s revenue, profitability, outlook and overall business strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from the information contained in the forward-looking statements. These risks, uncertainties and other factors include, without limitation: (i) the Company’s inability to effectively operate its facilities; (ii) the Company’s reliance on its sales and marketing program to continuously attract and enroll clients; (iii) a reduction in reimbursement rates by certain third-party payors for inpatient and outpatient services and point-of-care and definitive lab testing; (iv) the Company’s failure to successfully achieve growth through acquisitions and de novo projects; (v) risks associated with estimates of the value of accounts receivable or deterioration in collectability of accounts receivable; (vi) a failure to achieve anticipated financial results from contemplated and prior acquisitions; (vii) the possibility that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of an acquisition; (viii) the Company’s failure to achieve anticipated financial results from contemplated and prior acquisitions; (ix) a disruption in the Company’s ability to perform diagnostic laboratory services; (x) maintaining compliance with applicable regulatory authorities, licensure and permits to operate the Company’s facilities and laboratories; (xi) a disruption in the Company’s business and reputational and economic risks associated with the civil securities claims brought by shareholders or claims by various parties; (xii) inability to meet the covenants in the Company’s loan documents or lack of borrowing capacity, including the Company’s inability to enter into forbearance agreements and amendments with its lenders with respect to certain events of default; (xiii) inability to successfully raise capital to meet the Company’s liquidity needs; and (xiv) general economic conditions, as well as other risks discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 and other filings with the Securities and Exchange Commission. As a result of these factors, we cannot assure you that the forward-looking statements in this release will prove to be accurate. Investors should not place undue reliance upon forward-looking statements. The Company is in the process of finalizing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, including the process of reviewing the financial statements contained therein. Results reported in this earnings release could change as a result of this process.

5

 


AAC HOLDINGS, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

Unaudited

 

(Dollars in thousands, except share data)

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

June 30, 2019

 

 

March 31, 2019

 

Revenues

 

 

 

 

 

 

 

Client related revenue

$

60,595

 

 

$

53,489

 

Non-client related revenue

 

2,129

 

 

 

1,881

 

Total revenues

 

62,724

 

 

 

55,370

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

Salaries, wages and benefits

 

38,928

 

 

 

40,553

 

Client related services

 

5,975

 

 

 

6,041

 

Advertising and marketing

 

2,725

 

 

 

3,295

 

Professional fees

 

5,557

 

 

 

4,122

 

Other operating expenses

 

10,260

 

 

 

11,363

 

Rentals and leases

 

2,094

 

 

 

2,000

 

Litigation settlement

 

 

 

 

(1,238

)

Depreciation and amortization

 

3,572

 

 

 

4,344

 

Gain on sale

 

 

 

 

(1,010

)

Total operating expenses

 

69,111

 

 

 

69,470

 

Loss from operations

 

(6,387

)

 

 

(14,100

)

Interest expense, net

 

12,582

 

 

 

10,260

 

Other income, net

 

(232

)

 

 

(211

)

Loss before income tax benefit

 

(18,737

)

 

 

(24,149

)

Income tax expense (benefit)

 

323

 

 

 

(33

)

Net loss

 

(19,060

)

 

 

(24,116

)

Less: net loss attributable to noncontrolling interest

 

2,688

 

 

 

2,097

 

Net loss attributable to AAC Holdings, Inc. common stockholders

$

(16,372

)

 

$

(22,019

)

 

 

 

 

 

 

 

 

Basic (loss) earnings per common share

$

(0.66

)

 

$

(0.90

)

Diluted (loss) earnings per common share

$

(0.66

)

 

$

(0.90

)

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

Basic

 

24,741,530

 

 

 

24,495,163

 

Diluted

 

24,741,530

 

 

 

24,495,163

 


6

 


AAC HOLDINGS, INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

Unaudited

 

(Dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

June 30

 

 

December 31

 

 

 

2019

 

 

2018

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

2,581

 

 

$

5,409

 

Accounts receivable, net of allowances

 

 

48,747

 

 

 

47,860

 

Prepaid expenses and other current assets

 

 

1,963

 

 

 

10,695

 

Total current assets

 

 

53,291

 

 

 

63,964

 

Property and equipment, net

 

 

160,749

 

 

 

166,921

 

Right-of-use assets, net

 

 

28,328

 

 

 

 

Goodwill

 

 

198,952

 

 

 

198,952

 

Intangible assets, net

 

 

10,383

 

 

 

12,063

 

Other assets

 

 

11,362

 

 

 

10,377

 

Total assets

 

$

463,065

 

 

$

452,277

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

17,744

 

 

$

13,507

 

Accrued and other current liabilities

 

 

31,998

 

 

 

30,423

 

Accrued litigation

 

 

3,493

 

 

 

8,000

 

Current portion of lease liability

 

 

5,109

 

 

 

121

 

Current portion of long-term debt

 

 

334,534

 

 

 

309,394

 

Current portion of financing lease obligation

 

 

24,489

 

 

 

 

Total current liabilities

 

 

417,367

 

 

 

361,445

 

Deferred tax liabilities

 

 

1,402

 

 

 

1,227

 

Long-term debt, net of current portion and debt issuance costs

 

 

7,384

 

 

 

9,764

 

Lease liability, net of current portion

 

 

28,325

 

 

 

 

Financing lease obligation, net of current portion

 

 

 

 

 

24,421

 

Other long-term liabilities

 

 

8,139

 

 

 

13,147

 

Total liabilities

 

 

462,617

 

 

 

410,004

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

27,373

 

 

 

64,413

 

Noncontrolling interest

 

 

(26,925

)

 

 

(22,140

)

Total stockholders’ equity including noncontrolling interest

 

 

448

 

 

 

42,273

 

Total liabilities and stockholders’ equity

 

$

463,065

 

 

$

452,277

 


7

 


AAC HOLDINGS, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Unaudited

 

(Dollars in thousands)

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

June 30, 2019

 

 

March 31, 2019

 

Cash flows used in operating activities:

 

 

 

 

 

 

 

Net loss

$

(19,060

)

 

$

(24,116

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

3,572

 

 

 

4,344

 

Equity compensation

 

850

 

 

 

364

 

Loss on disposal of property and equipment

 

465

 

 

 

145

 

Amortization of debt issuance costs

 

728

 

 

 

1,243

 

Deferred income taxes

 

265

 

 

 

(90

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

(3,063

)

 

 

2,176

 

Prepaid expenses and other assets

 

1,701

 

 

 

7,808

 

Accounts payable

 

577

 

 

 

3,660

 

Accrued and other current liabilities

 

3,040

 

 

 

4,819

 

Accrued litigation

 

(1,334

)

 

 

(3,173

)

Other long-term liabilities

 

(1,227

)

 

 

(6,763

)

Net cash used in operating activities

 

(13,486

)

 

 

(9,583

)

Cash flows used in investing activities:

 

 

 

 

 

 

 

Purchase of property and equipment

 

(1,075

)

 

 

(913

)

Sale of subsidiary

 

 

 

 

887

 

Net cash used in investing activities

 

(1,075

)

 

 

(26

)

Cash flows (used in) provided by financing activities:

 

 

 

 

 

 

 

Payments on 2017 Credit Facility

 

(1,724

)

 

 

(1,924

)

Proceeds from 2019 Priming Facility, net of deferred financing costs

 

260

 

 

 

24,284

 

Proceeds from 2017 Credit Facility, net of deferred financing costs

 

1,211

 

 

 

250

 

Payments on finance leases and other

 

(224

)

 

 

(291

)

Payments on AdCare Note

 

(250

)

 

 

(250

)

Net cash (used in) provided by financing activities

 

(727

)

 

 

22,069

 

Net change in cash and cash equivalents

 

(15,288

)

 

 

12,460

 

Cash and cash equivalents, beginning of period

 

17,869

 

 

 

5,409

 

Cash and cash equivalents, end of period

$

2,581

 

 

$

17,869

 

 

8

 


AAC HOLDINGS, INC.

 

OPERATING METRICS

 

Unaudited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months

Ended

 

 

Six Months Ended

 

 

June 30, 2019

 

 

March 31, 2019

 

 

June 30, 2019

 

Operating Metrics:

 

 

 

 

 

 

 

 

 

 

 

New admissions1

 

4,830

 

 

 

4,641

 

 

 

9,471

 

Average daily inpatient census2

 

802

 

 

 

740

 

 

 

771

 

Average daily sober living census3

 

185

 

 

 

213

 

 

 

199

 

Total average daily census

 

987

 

 

 

953

 

 

 

970

 

Average episode length (days)4

 

19

 

 

 

19

 

 

 

19

 

Average daily inpatient revenue5

$

790

 

 

$

674

 

 

$

735

 

Revenue per admission6

$

12,546

 

 

$

11,525

 

 

$

12,046

 

Outpatient visits7

 

37,903

 

 

 

39,717

 

 

 

77,620

 

Revenue per outpatient visit8

$

143

 

 

$

162

 

 

$

153

 

Client related diagnostic services9

 

(4

%)

 

 

4

%

 

 

0

%

Inpatient bed count at end of period10

 

996

 

 

 

996

 

 

 

996

 

Effective inpatient bed count at end of period11

 

992

 

 

 

992

 

 

 

992

 

Average effective inpatient bed utilization12

 

81

%

 

 

75

%

 

 

78

%

 

1    Represents total client admissions at our inpatient facilities for the periods presented.

2    Represents average daily client census at all of our inpatient facilities.

3    Represents average daily client census at our sober living facilities.

4    Average episode length is the consecutive number of days from admission to discharge that a client stays at an AAC inpatient facility and, when applicable, an AAC sober living facility.

5    Average daily inpatient revenue is calculated as total revenues from all of our inpatient facilities during the period, divided by the product of the number of days in the period multiplied by average daily inpatient census.

6    Revenue per admission is calculated by dividing total client related revenue by new admissions.

7    Represents the total number of outpatient visits at our standalone outpatient centers during the periods presented.

8    Revenue per outpatient visit is calculated as total revenues from all of our standalone outpatient facilities divided by the number of outpatient visits during the period.

9    Client related diagnostic services revenue, as a percentage of client related revenue, includes point-of-care and client related diagnostic laboratory services.

10   Inpatient bed count at end of period includes all beds at inpatient facilities.

11   Effective bed count at end of period represents the number of beds for which our facilities are staffed based on planned census.  

12   Average effective inpatient bed utilization represents average daily inpatient census divided by the average effective inpatient bed count during the applicable period.

9

 


AAC HOLDINGS, INC.

 

SUPPLEMENTAL RECONCILIATION OF NON-GAAP DISCLOSURES

 

Unaudited

 

(Dollars in thousands)

 

Reconciliation of Adjusted EBITDA to Net Loss (Income) Attributable to AAC Holdings, Inc. Common Stockholders

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

June 30, 2019

 

 

March 31, 2019

 

Net loss attributable to AAC Holdings, Inc. common stockholders

 

$

(16,372

)

 

$

(22,019

)

Non-GAAP Adjustments1:

 

 

 

 

 

 

 

 

Interest expense

 

 

12,582

 

 

 

10,260

 

Depreciation and amortization

 

 

3,572

 

 

 

4,344

 

Income tax benefit

 

 

323

 

 

 

(33

)

Net loss attributable to noncontrolling interest

 

 

(2,688

)

 

 

(2,097

)

Stock-based compensation and other

 

 

1,539

 

 

 

364

 

Litigation settlement, regulatory and California matter related expense

 

 

66

 

 

 

(988

)

Acquisition-related expense

 

 

40

 

 

 

28

 

Transaction costs

 

 

532

 

 

 

1,517

 

Recruitment and retention expense

 

 

50

 

 

 

375

 

Employee severance expense

 

 

185

 

 

 

1,098

 

Facility closure operating losses and expense

 

 

3,059

 

 

 

647

 

Adjusted EBITDA

 

$

2,888

 

 

$

(6,504

)

 

1    Adjusted EBITDA, adjusted net (loss) income attributable to AAC Holdings, Inc. common stockholders and adjusted diluted earnings per common share (herein collectively referred to as "Non-GAAP Disclosures") are “non-GAAP financial measures” as defined under the rules and regulations promulgated by the U.S. Securities and Exchange Commission, each of which are defined below. Management has chosen to present these NonGAAP Disclosures to investors to enable additional analyses of past, present and future operating performance and as a supplemental means of evaluating operations absent the effect of certain items that we do not consider indicative of our ongoing core operating performance or are non-cash items. Certain of these items may recur in the future. Management believes the Non-GAAP Disclosures provide investors with additional meaningful financial information that should be considered when assessing our underlying business performance and trends. We believe the Non-GAAP Disclosures also enhance investors’ ability to compare period-to-period financial results. The Non-GAAP Disclosures should not be considered as measures of financial performance under U.S. generally accepted accounting principles ("GAAP"). The items excluded from the Non-GAAP Disclosures are significant components in understanding and assessing our financial performance and should not be considered as an alternative to net income or other financial statement items presented in the condensed consolidated financial statements. Because the Non-GAAP Disclosures are not measures determined in accordance with GAAP, the Non-GAAP Disclosures may not be comparable to other similarly titled measures of other companies.  

10

 


Management defines adjusted EBITDA as net loss attributable to AAC Holdings, Inc. common stockholders adjusted for interest expense, depreciation and amortization expense, income tax benefit, net loss attributable to noncontrolling interest, stock-based compensation and related tax reimbursements, litigation settlement, certain regulatory and California matter related expenses, acquisition-related expense (which includes professional services for accounting, legal, valuation services and licensing expenses), de novo start-up and other expenses, recruitment and retention expense, employee severance expense and facility closure operating losses and expense.


11

 


AAC HOLDINGS, INC.

 

SUPPLEMENTAL RECONCILIATION OF NON-GAAP DISCLOSURES

 

Unaudited

 

(Dollars in thousands, except share data)

 

Reconciliation of Adjusted Net (Loss) Income Attributable to AAC Holdings, Inc. Common Stockholders to Net (Loss) Income Attributable to AAC Holdings, Inc. Common Stockholders

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

June 30, 2019

 

 

March 31, 2019

 

Net loss attributable to AAC Holdings, Inc. common stockholders

 

$

(16,372

)

 

$

(22,019

)

Non-GAAP Adjustments:

 

 

 

 

 

 

 

 

Litigation settlement, regulatory and California matter related expense

 

 

66

 

 

 

(988

)

Acquisition-related expense

 

 

40

 

 

 

28

 

Transaction costs

 

 

532

 

 

 

1,517

 

Recruitment and retention expense

 

 

50

 

 

 

375

 

Employee severance expense

 

 

185

 

 

 

1,098

 

Facility closure operating losses and expense

 

 

3,059

 

 

 

647

 

Income tax effect of non-GAAP adjustments

 

 

 

 

 

(4

)

Adjusted net (loss) income attributable to AAC Holdings, Inc. common

   stockholders

 

$

(12,440

)

 

$

(19,346

)

Weighted-average common shares outstanding - diluted

 

 

24,741,530

 

 

 

24,495,163

 

GAAP diluted (loss) income per common share

 

$

(0.66

)

 

$

(0.90

)

Adjusted (loss) earnings per diluted common share

 

$

(0.50

)

 

$

(0.79

)

 

Management defines adjusted net loss attributable to AAC Holdings, Inc. common stockholders as net loss attributable to AAC Holdings, Inc. common stockholders adjusted for litigation settlement, certain regulatory and California matter related expenses, acquisition-related expense (which includes professional services for accounting, legal, valuation services and licensing expenses), de novo start-up and other expenses, recruitment and retention expense, employee severance expense, facility closure operating losses and expense and the income tax effect of the non-GAAP adjustments at the then applicable effective tax rate.

Adjusted diluted earnings per common share represents diluted earnings per common share calculated using adjusted net income attributable to AAC Holdings, Inc. common stockholders as opposed to net income attributable to AAC Holdings, Inc. common stockholders.

12

 

(Back To Top)

Section 3: EX-99.2 (EX-99.2)

aac-ex992_10.pptx.htm

Slide 1

Earnings Release Supplement August 2019

Slide 2

Notice to Investors We use market data and industry forecasts and projections throughout this presentation, including data from publicly available information and industry publications. These sources generally state that the information they provide has been obtained from sources believed to be reliable, but that the accuracy and completeness of the information are not guaranteed. The forecasts and projections are based on industry surveys and the preparers’ experience in the industry, and there can be no assurance that any of the forecasts or projections will be achieved. We believe that the surveys and market research others have performed are reliable, but we have not independently investigated or verified this information. Forecasts and other forward-looking information obtained from these sources are subject to the same qualifications and uncertainties as the other forward-looking statements contained in this presentation. important presentation information

Slide 3

Forward-Looking Statements Some of the statements made in this presentation constitute forward-looking statements within the meaning of federal securities laws. Forward-looking statements reflect our current views with respect to future events and performance. In some cases you can identify forward-looking statements by terminology such as “may,” “might, “will,” “should,” “could” or the negative thereof. Generally, the words “anticipate,” “believe,” “continues,” “expect,” “intend,” “estimate,” “project,” “plan” and similar expressions identify forward-looking statements. In particular, statements about our pipeline, industry growth opportunities, disclosure of key performance indicators, business growth strategy and financial guidance in this presentation are forward-looking statements. We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks, uncertainties and other factors, many of which are outside of our control, which could cause our actual results, performance or achievements to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements. For additional discussion of risks, uncertainties and other factors, see the section titled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and our subsequent filings with the United States Securities and Exchange Commission (the “SEC"). Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. These risks and uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. These forward-looking statements are made only as of the date of this presentation. We do not undertake and specifically decline any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments. The Company is in the process of finalizing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, including the process of reviewing the financial statements contained therein. Results reported in this presentation could change as  result of this process.     important presentation information

Slide 4

54 admits /day 45 admits /day 53 admits /day 55 admits /day New Admissions Average Admissions per Day have increased over 20% YTD through July ’19 52 admits /day 55 admits /day * Based on actual July 2019 admissions of 1,714

Slide 5

Total Average Daily Census (ADC)

Slide 6

Net Revenue Operating Expenses* Adjusted EBITDA** Summarized Financials Summarized financials * Operating expenses exclude depreciation and amortization, gain on sale and litigation settlement $ in millions ** Refer to the Appendix for a reconciliation of Adjusted EBITDA.

Slide 7

2019 Guidance Bridge 2019 Guidance Bridge $ in millions Revenue Adjusted EBITDA Full Year 2019 Guidance $255 - $275 $16 - $21 Q1 2019 (Actual) $55.0 -$7 Q2 2019 (Actual) $63.0 $3 1H 2019 (Actual) $118 -$4 Implied 2H 2019 Guidance $137 - $157 $20 - $25

Slide 8

ADJUStED EBITDA Bridge to 2H 2019 Implied Guidance Adjusted EBITDA A Adjusted EBITDA Bridge to 2H 2019 Implied Guidance $ in millions Client Diagnostic Services: Included in AEBITDA for Q2 2019 was an increase in reserves on accounts receivable for client related diagnostic services of approximately $4 million. This adjustment is not expected to re-occur in future periods $4 million X 2 quarters = $8 million Census Improvement: 2H 2019 implied guidance assumes an average census improvement of approximately 4% from Q2 ’19 July 2019 average census improved 2% from Q2 2019 Operating Expenses Operating expenses assume an additional $4 million in reduced operating expenses for the 2H 2019. A B C A B C * Q2 2019 AEBITDA of ~$3MM X 2 (6 MONTH RUN RATE)

Slide 9

Appendix: Reconciliation of AEBITDA

(Back To Top)